Relmada Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20k | 10k | 2.01 |
| 2025-06-30 | $0 | 1 | 0.00 |
| 2024-12-31 | $76k | 146k | 0.52 |
| 2024-09-30 | $473k | 146k | 3.24 |
| 2024-06-30 | $438k | 146k | 3.00 |
| 2024-03-31 | $679k | 146k | 4.65 |
| 2023-12-31 | $604k | 146k | 4.14 |
| 2023-09-30 | $438k | 146k | 3.00 |
| 2023-06-30 | $359k | 146k | 2.46 |
| 2023-03-31 | $33k | 15k | 2.24 |
| 2022-12-31 | $40k | 12k | 3.48 |
| 2022-09-30 | $263k | 7.1k | 37.04 |
| 2022-06-30 | $317k | 17k | 18.97 |
| 2022-03-31 | $46k | 1.7k | 27.06 |